/Passle/64d4f6fee800c20fd466fd0c/SearchServiceImages/2024-04-30-16-24-01-910-66311b21145aa375cc9bb37c.jpg)
As discussed in November and December, the FTC has placed improper Orange Book patent listings squarely in its crosshairs. Initially,...
/Passle/64d4f6fee800c20fd466fd0c/SearchServiceImages/2024-04-29-18-43-07-202-662fea3b7a56bfff0cd9e58d.jpg)
Expanding the range of ways they can identify and investigate potential competition concerns in healthcare, DOJ, FTC, and HHS recently...
/Passle/64d4f6fee800c20fd466fd0c/SearchServiceImages/2024-04-23-21-32-18-196-662828e20867261767c7a28b.jpg)
On April 15, 2024, in response to feedback on last year's ANPRM, Director Vidal issued an invitation to comment on the new NPRM governing...
/Passle/64d4f6fee800c20fd466fd0c/SearchServiceImages/2024-04-23-20-09-42-162-66281586160531884bce17ee.jpg)
Today, the U.S. Federal Trade Commission (“FTC”) adopted a final rule (3-2) banning new non-compete agreements for both senior executives...
/Passle/64d4f6fee800c20fd466fd0c/SearchServiceImages/2024-04-22-20-50-36-742-6626cd9cd100dba38ac0e957.jpg)
Two weeks ago we discussed Vanda Pharmaceuticals’ ambitious cert petition asking the Supreme Court to discontinue the “reasonable...
/Passle/64d4f6fee800c20fd466fd0c/MediaLibrary/Images/2024-04-22-18-18-54-912-6626aa0e1f76e96e6865bc46.jpg)
Many practitioners wonder what it would be like to be an academic, diving deeply into the leading international legal and policy issues...
/Passle/64d4f6fee800c20fd466fd0c/MediaLibrary/Images/2024-04-19-21-26-04-363-6622e16c110ebb812e95cc5e.png)
This is part three of our USITC Commissioner Series. Read part one here, part two here, part four here and part five here. Following my...
/Passle/64d4f6fee800c20fd466fd0c/SearchServiceImages/2024-04-19-14-17-54-965-66227d126f4c71deb046b4ab.jpg)
The FTC's proposed ban on labor non-competes has loomed since January 2023, with a vote now scheduled for April 23, 2024 in a special...
/Passle/64d4f6fee800c20fd466fd0c/MediaLibrary/Images/2024-04-18-18-38-28-379-662168a4d52a0531835fb4b1.jpg)
This is part two of our USITC Commissioner Series. Read part one here and part three here, part four here, and part five here. As my...
/Passle/64d4f6fee800c20fd466fd0c/SearchServiceImages/2024-04-15-13-59-57-739-661d32ddb109ba905034771e.jpg)
Can a patentee really just take a pass on alleging that an accused product meets a limitation in an asserted claim, even where the case...
/Passle/64d4f6fee800c20fd466fd0c/SearchServiceImages/2024-04-10-15-49-50-207-6616b51e540c69b3b6ce50d5.jpg)
We previously wrote about the surprising power of the Connecticut Prejudgment Remedy (PJR) statute, which allows litigants to seek an...
/Passle/64d4f6fee800c20fd466fd0c/SearchServiceImages/2024-04-08-19-23-57-796-6614444ddb431f62a29d4624.jpg)
Among the most established standards in patent law is that obviousness requires a motivation to combine the prior art with “a reasonable...
/Passle/64d4f6fee800c20fd466fd0c/SearchServiceImages/2024-04-05-20-27-50-773-66105ec6e93626c9a832ac88.jpg)
A claimant's recovery of attorneys' fees in a trade secret action ordinarily reflects an overwhelming success at trial. The claimant...
/Passle/64d4f6fee800c20fd466fd0c/SearchServiceImages/2024-04-04-18-50-50-278-660ef68a8211d1eddd9ffa0c.jpg)
Much like secondary considerations, non-infringing alternatives fit imperfectly within many scheduling orders. The patentee has the...